Chesnara Plc: Acquisitions show immediate benefits
2 September 2026
Emergent BioSolutions Inc. (NYSE: EBS), a company with a pivotal role in public health preparedness and response, is currently capturing investor attention with a potential upside of nearly 77%. Situated..
Akso Health Group (AHG), a burgeoning player in the Healthcare sector, is making waves with its impressive revenue growth, despite the challenges it faces in the volatile medical distribution industry...
Prothena Corporation plc (NASDAQ: PRTA), a biotechnology company headquartered in Dublin, Ireland, is capturing attention in the healthcare sector with its innovative approach to tackling diseases caused by protein dysregulation...
Investors with a keen eye on the biotechnology sector might want to take a closer look at PureTech Health plc (PRTC), a company making significant strides in the development and..
Geron Corporation (NASDAQ: GERN), a biopharmaceutical company at the forefront of oncology therapeutics, is garnering investor interest with its significant potential upside. With a current market capitalization of $880.46 million,..
In the ever-evolving landscape of healthcare, biotechnology companies like Upstream Bio, Inc. (NASDAQ: UPB) are attracting significant attention from investors, driven by their innovative approaches to treating complex diseases. With..
HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the healthcare information services sector, is making waves with its cutting-edge Software-as-a-Service (SaaS) solutions. Headquartered in Nashville, Tennessee, HealthStream is well-positioned to..
Inventiva S.A. – American Depositary Shares (IVA), a France-based clinical-stage biopharmaceutical company, is garnering significant attention in the biotechnology sector with its ambitious therapeutic pipeline. As a healthcare entity listed..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) stands out in the biotechnology sector as a clinical-stage company focused on innovative cancer treatments. With a market capitalization of $1.05 billion, ORIC is gaining..
Theravance Biopharma, Inc. (NASDAQ: TBPH), a player in the biotechnology sector, is catching the attention of investors with a notable potential upside of 30.96%. This U.S.-based company, with a market..
Zenas BioPharma, Inc. (ZBIO), a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, is making waves in the biotechnology sector with its focus on transformative immunology-based therapies. As the company continues..
Investors seeking opportunities in the biotechnology sector may find Oruka Therapeutics, Inc. (NASDAQ: ORKA) particularly enticing. With a potential upside of 163.86% based on the average target price, Oruka is..
Iovance Biotherapeutics, Inc. (IOVA), a pioneering entity in the biotechnology sector, is attracting significant investor attention with its revolutionary approach to cancer treatment and a remarkable 313% potential upside. This..
Community Health Systems, Inc. (NYSE: CYH), a key player in the healthcare sector, operates in the medical care facilities industry within the United States. With a current market capitalization of..
Pharvaris N.V. (PHVS), a Swiss-based biotechnology company, is making waves in the healthcare sector with its innovative approach to treating rare diseases. Specializing in the development and commercialization of therapies..
Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company, is attracting considerable attention in the healthcare sector. With a market capitalization of $629.54 million, the company is dedicated to the discovery..
Trevi Therapeutics, Inc. (NASDAQ: TRVI) is a clinical-stage biopharmaceutical company that has been capturing investor attention with its promising therapeutic developments and significant growth potential. With a current market cap..
REGENXBIO Inc. (NASDAQ: RGNX), a clinical-stage biotechnology company, is capturing the attention of investors with a striking potential upside of 215.82%. Operating in the healthcare sector, REGENXBIO focuses on developing..
